期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Current status and prospect of treatments for recurrent hepatocellular carcinoma 被引量:4
1
作者 Yu-Qing Yang Zhen-Yu Wen +5 位作者 Xiao-Yan Liu zhen-hu ma Yan-E Liu Xue-Ying Cao Li Hou Xie Hui 《World Journal of Hepatology》 2023年第2期129-150,共22页
Owing to its heterogeneous and highly aggressive nature,hepatocellular carcinoma(HCC)has a high recurrence rate,which is a non-negligible problem despite the increasing number of available treatment options.Recent cli... Owing to its heterogeneous and highly aggressive nature,hepatocellular carcinoma(HCC)has a high recurrence rate,which is a non-negligible problem despite the increasing number of available treatment options.Recent clinical trials have attempted to reduce the recurrence and develop innovative treatment options for patients with recurrent HCC.In the event of liver remnant recurrence,the currently available treatment options include repeat hepatectomy,salvage liver transplantation,tumor ablation,transcatheter arterial chemoembolization,stereotactic body radiotherapy,systemic therapies,and combination therapy.In this review,we summarize the strategies to reduce the recurrence of high-risk tumors and aggressive therapies for recurrent HCC.Additionally,we discuss methods to prevent HCC recurrence and prognostic models constructed based on predictors of recurrence to develop an appropriate surveillance program. 展开更多
关键词 REVIEW RECURRENCE Hepatocellular carcinoma HEPATECTOMY Liver transplantation Transcatheter arterial chemoembolization
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部